Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
32
ADGM Quote, Financials, Valuation and Earnings
Last price:
$1.97
Seasonality move
:
1.39%
Day range:
$1.36 - $1.97
52-week range:
$1.36 - $11.57
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.59x
Volume:
284.1K
Avg. volume:
158.2K
1-year change:
-83.98%
Market cap:
$13.2M
Revenue:
--
EPS (TTM):
-$0.27
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ADGM
Adagio Medical Holdings
|
-- | -- | -- | -- | -- |
|
AIMD
Ainos
|
-- | -- | -- | -- | -- |
|
INBS
Intelligent Bio Solutions
|
$1.4M | -- | 160.36% | -- | -- |
|
LAB
Standard BioTools
|
$41M | -$0.08 | 52.67% | -88% | -- |
|
LNSR
LENSAR
|
$11.5M | -$0.30 | 23.5% | -48.57% | -- |
|
ZOM
Zomedica
|
-- | -- | 10.4% | -72% | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ADGM
Adagio Medical Holdings
|
$1.75 | -- | $13.2M | -- | $0.00 | 0% | -- |
|
AIMD
Ainos
|
$0.45 | -- | $6.2M | -- | $0.00 | 0% | 33.57x |
|
INBS
Intelligent Bio Solutions
|
$1.33 | -- | $5.8M | -- | $0.00 | 0% | 0.62x |
|
LAB
Standard BioTools
|
$2.00 | -- | $744.5M | -- | $0.00 | 0% | 3.58x |
|
LNSR
LENSAR
|
$7.70 | -- | $89.4M | -- | $0.00 | 0% | 1.80x |
|
ZOM
Zomedica
|
$0.13 | -- | $122.8M | -- | $0.00 | 0% | 4.59x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ADGM
Adagio Medical Holdings
|
-- | 0.626 | -- | -- |
|
AIMD
Ainos
|
20.03% | 0.945 | 81.11% | 0.22x |
|
INBS
Intelligent Bio Solutions
|
7.57% | 6.876 | 6.74% | 0.92x |
|
LAB
Standard BioTools
|
10.14% | -0.573 | 7.68% | 3.33x |
|
LNSR
LENSAR
|
-- | 4.014 | -- | 1.95x |
|
ZOM
Zomedica
|
-- | 2.172 | -- | 9.83x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ADGM
Adagio Medical Holdings
|
-- | -$611.7K | -- | -- | -- | -$511.7K |
|
AIMD
Ainos
|
-$550 | -$3M | -45.16% | -52.95% | -15756.26% | -$1.5M |
|
INBS
Intelligent Bio Solutions
|
$346.8K | -$2.7M | -161.24% | -176.44% | -306.38% | -$2.4M |
|
LAB
Standard BioTools
|
$23.3M | -$24.3M | -39.17% | -48.03% | -54.03% | -$30.1M |
|
LNSR
LENSAR
|
$6.3M | -$1.2M | -56.16% | -56.16% | -9.2% | $3.1M |
|
ZOM
Zomedica
|
$5.1M | -$7.4M | -27.17% | -27.17% | -96.1% | -$5.9M |
Adagio Medical Holdings vs. Competitors
-
Which has Higher Returns ADGM or AIMD?
Ainos has a net margin of -- compared to Adagio Medical Holdings's net margin of -15991.17%. Adagio Medical Holdings's return on equity of -- beat Ainos's return on equity of -52.95%.
Company Gross Margin Earnings Per Share Invested Capital ADGMAdagio Medical Holdings-- -$0.03 -- AIMDAinos-29.07% -$0.33 $28.4M -
What do Analysts Say About ADGM or AIMD?
Adagio Medical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Ainos has an analysts' consensus of -- which suggests that it could fall by --. Given that Adagio Medical Holdings has higher upside potential than Ainos, analysts believe Adagio Medical Holdings is more attractive than Ainos.
Company Buy Ratings Hold Ratings Sell Ratings ADGMAdagio Medical Holdings0 0 0 AIMDAinos0 0 0 -
Is ADGM or AIMD More Risky?
Adagio Medical Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ainos has a beta of 1.417, suggesting its more volatile than the S&P 500 by 41.704%.
-
Which is a Better Dividend Stock ADGM or AIMD?
Adagio Medical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ainos offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Adagio Medical Holdings pays -- of its earnings as a dividend. Ainos pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ADGM or AIMD?
Adagio Medical Holdings quarterly revenues are --, which are smaller than Ainos quarterly revenues of $20.7K. Adagio Medical Holdings's net income of -$245.9K is higher than Ainos's net income of -$3.7M. Notably, Adagio Medical Holdings's price-to-earnings ratio is -- while Ainos's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Adagio Medical Holdings is -- versus 33.57x for Ainos. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ADGMAdagio Medical Holdings-- -- -- -$245.9K AIMDAinos33.57x -- $20.7K -$3.7M
-
Which has Higher Returns ADGM or INBS?
Intelligent Bio Solutions has a net margin of -- compared to Adagio Medical Holdings's net margin of -307.88%. Adagio Medical Holdings's return on equity of -- beat Intelligent Bio Solutions's return on equity of -176.44%.
Company Gross Margin Earnings Per Share Invested Capital ADGMAdagio Medical Holdings-- -$0.03 -- INBSIntelligent Bio Solutions39.76% -$8.40 $6.4M -
What do Analysts Say About ADGM or INBS?
Adagio Medical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Intelligent Bio Solutions has an analysts' consensus of -- which suggests that it could grow by 802.26%. Given that Intelligent Bio Solutions has higher upside potential than Adagio Medical Holdings, analysts believe Intelligent Bio Solutions is more attractive than Adagio Medical Holdings.
Company Buy Ratings Hold Ratings Sell Ratings ADGMAdagio Medical Holdings0 0 0 INBSIntelligent Bio Solutions0 0 0 -
Is ADGM or INBS More Risky?
Adagio Medical Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Intelligent Bio Solutions has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock ADGM or INBS?
Adagio Medical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intelligent Bio Solutions offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Adagio Medical Holdings pays -- of its earnings as a dividend. Intelligent Bio Solutions pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ADGM or INBS?
Adagio Medical Holdings quarterly revenues are --, which are smaller than Intelligent Bio Solutions quarterly revenues of $872.3K. Adagio Medical Holdings's net income of -$245.9K is higher than Intelligent Bio Solutions's net income of -$2.7M. Notably, Adagio Medical Holdings's price-to-earnings ratio is -- while Intelligent Bio Solutions's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Adagio Medical Holdings is -- versus 0.62x for Intelligent Bio Solutions. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ADGMAdagio Medical Holdings-- -- -- -$245.9K INBSIntelligent Bio Solutions0.62x -- $872.3K -$2.7M
-
Which has Higher Returns ADGM or LAB?
Standard BioTools has a net margin of -- compared to Adagio Medical Holdings's net margin of -59.9%. Adagio Medical Holdings's return on equity of -- beat Standard BioTools's return on equity of -48.03%.
Company Gross Margin Earnings Per Share Invested Capital ADGMAdagio Medical Holdings-- -$0.03 -- LABStandard BioTools51.73% -$0.07 $544.5M -
What do Analysts Say About ADGM or LAB?
Adagio Medical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Standard BioTools has an analysts' consensus of -- which suggests that it could grow by 54.17%. Given that Standard BioTools has higher upside potential than Adagio Medical Holdings, analysts believe Standard BioTools is more attractive than Adagio Medical Holdings.
Company Buy Ratings Hold Ratings Sell Ratings ADGMAdagio Medical Holdings0 0 0 LABStandard BioTools0 0 0 -
Is ADGM or LAB More Risky?
Adagio Medical Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Standard BioTools has a beta of 1.606, suggesting its more volatile than the S&P 500 by 60.617%.
-
Which is a Better Dividend Stock ADGM or LAB?
Adagio Medical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Adagio Medical Holdings pays -- of its earnings as a dividend. Standard BioTools pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ADGM or LAB?
Adagio Medical Holdings quarterly revenues are --, which are smaller than Standard BioTools quarterly revenues of $45M. Adagio Medical Holdings's net income of -$245.9K is higher than Standard BioTools's net income of -$26.9M. Notably, Adagio Medical Holdings's price-to-earnings ratio is -- while Standard BioTools's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Adagio Medical Holdings is -- versus 3.58x for Standard BioTools. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ADGMAdagio Medical Holdings-- -- -- -$245.9K LABStandard BioTools3.58x -- $45M -$26.9M
-
Which has Higher Returns ADGM or LNSR?
LENSAR has a net margin of -- compared to Adagio Medical Holdings's net margin of -11.09%. Adagio Medical Holdings's return on equity of -- beat LENSAR's return on equity of -56.16%.
Company Gross Margin Earnings Per Share Invested Capital ADGMAdagio Medical Holdings-- -$0.03 -- LNSRLENSAR46.28% -$0.13 $22.7M -
What do Analysts Say About ADGM or LNSR?
Adagio Medical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand LENSAR has an analysts' consensus of -- which suggests that it could grow by 42.86%. Given that LENSAR has higher upside potential than Adagio Medical Holdings, analysts believe LENSAR is more attractive than Adagio Medical Holdings.
Company Buy Ratings Hold Ratings Sell Ratings ADGMAdagio Medical Holdings0 0 0 LNSRLENSAR0 0 0 -
Is ADGM or LNSR More Risky?
Adagio Medical Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison LENSAR has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock ADGM or LNSR?
Adagio Medical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENSAR offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Adagio Medical Holdings pays -- of its earnings as a dividend. LENSAR pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ADGM or LNSR?
Adagio Medical Holdings quarterly revenues are --, which are smaller than LENSAR quarterly revenues of $13.5M. Adagio Medical Holdings's net income of -$245.9K is higher than LENSAR's net income of -$1.5M. Notably, Adagio Medical Holdings's price-to-earnings ratio is -- while LENSAR's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Adagio Medical Holdings is -- versus 1.80x for LENSAR. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ADGMAdagio Medical Holdings-- -- -- -$245.9K LNSRLENSAR1.80x -- $13.5M -$1.5M
-
Which has Higher Returns ADGM or ZOM?
Zomedica has a net margin of -- compared to Adagio Medical Holdings's net margin of -95.71%. Adagio Medical Holdings's return on equity of -- beat Zomedica's return on equity of -27.17%.
Company Gross Margin Earnings Per Share Invested Capital ADGMAdagio Medical Holdings-- -$0.03 -- ZOMZomedica72.32% -$0.01 $202.8M -
What do Analysts Say About ADGM or ZOM?
Adagio Medical Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Zomedica has an analysts' consensus of -- which suggests that it could grow by 99.52%. Given that Zomedica has higher upside potential than Adagio Medical Holdings, analysts believe Zomedica is more attractive than Adagio Medical Holdings.
Company Buy Ratings Hold Ratings Sell Ratings ADGMAdagio Medical Holdings0 0 0 ZOMZomedica0 0 0 -
Is ADGM or ZOM More Risky?
Adagio Medical Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Zomedica has a beta of 1.044, suggesting its more volatile than the S&P 500 by 4.385%.
-
Which is a Better Dividend Stock ADGM or ZOM?
Adagio Medical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Zomedica offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Adagio Medical Holdings pays -- of its earnings as a dividend. Zomedica pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ADGM or ZOM?
Adagio Medical Holdings quarterly revenues are --, which are smaller than Zomedica quarterly revenues of $7M. Adagio Medical Holdings's net income of -$245.9K is higher than Zomedica's net income of -$6.7M. Notably, Adagio Medical Holdings's price-to-earnings ratio is -- while Zomedica's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Adagio Medical Holdings is -- versus 4.59x for Zomedica. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ADGMAdagio Medical Holdings-- -- -- -$245.9K ZOMZomedica4.59x -- $7M -$6.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
